These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 9738856

  • 21. [Resistance of Streptococcus pneumoniae to antibiotics].
    Simarro E, Ruiz J.
    Rev Esp Quimioter; 1998 Dec; 11(4):353-5. PubMed ID: 10336315
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998.
    Chokephaibulkit K, Srifuengfung S, Mingbanjerdsuk J, Tosasuk K, Vanprapar N, Chearskul S, Dhiraputra C.
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):498-505. PubMed ID: 11289009
    [Abstract] [Full Text] [Related]

  • 23. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I, Tillotson G.
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
    [No Abstract] [Full Text] [Related]

  • 25. Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality.
    Yu VL, Baddour LM.
    Clin Infect Dis; 2004 Oct 01; 39(7):1086-7; author reply 1087-8. PubMed ID: 15472872
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Fernández Viladrich P, Gudiol F.
    J Antimicrob Chemother; 2005 Nov 01; 56(5):979-82. PubMed ID: 16174686
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.
    Fenoll A, Aguilar L, Robledo O, Giménez MJ, Granizo JJ, Biek D, Tarragó D.
    J Antimicrob Chemother; 2008 Nov 01; 62(5):1156-8. PubMed ID: 18667449
    [No Abstract] [Full Text] [Related]

  • 28. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P, Finnish Study Group for Antimicrobial Resistance (FiRe-Network).
    Clin Infect Dis; 2001 Aug 15; 33(4):483-8. PubMed ID: 11462184
    [Abstract] [Full Text] [Related]

  • 29. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec 15; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 30. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF, Brazhnikova MG, Shorin VA, Maksimova TS, Ol'khovatova OL, Kudinova MK, Vishniakova IA, Pevzner NS, Shapovalova SP.
    Antibiotiki; 1970 Jun 15; 15(6):483-6. PubMed ID: 4394064
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea.
    Choi SH, Park SJ, Jun JB, Lee SR, Jeon MH, Kwon HH, Kim SC, Kim MN, Jeong JY, Woo JH, Kim YS.
    Diagn Microbiol Infect Dis; 2007 May 15; 58(1):141-3. PubMed ID: 17368803
    [Abstract] [Full Text] [Related]

  • 32. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae.
    Pramanik A, Stroeher UH, Krejci J, Standish AJ, Bohn E, Paton JC, Autenrieth IB, Braun V.
    Int J Med Microbiol; 2007 Oct 15; 297(6):459-69. PubMed ID: 17459767
    [Abstract] [Full Text] [Related]

  • 33. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.
    Pérez-Trallero E, Marimón JM, González A, Ercibengoa M, Larruskain J.
    Clin Infect Dis; 2005 Aug 15; 41(4):560-4. PubMed ID: 16028169
    [Abstract] [Full Text] [Related]

  • 34. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
    Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, Vesga O.
    BMC Infect Dis; 2006 Mar 17; 6():55. PubMed ID: 16545113
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A.
    East Mediterr Health J; 2005 Mar 17; 11(1-2):36-44. PubMed ID: 16532669
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.